Lexaria Bioscience (LEXX) Income Statement: Revenue & Earnings

Lexaria Bioscience Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Lexaria Bioscience Corp. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Aug 2024	Aug 2023	Aug 2022	Aug 2021
Revenue & Gross Profit
Revenue	0.71	0.46	0.23	0.26	0.72
Cost of Revenue	0.12	0.00	0.03	0.07	0.18
Gross Profit	0.59	0.46	0.19	0.18	0.55
Operating Expenses
Research & Development	8.24	2.36	3.67	1.84	1.26
Selling, General & Administrative	3.98	3.79	3.06	4.96	4.97
Operating Expenses	12.22	6.15	6.73	6.80	6.23
Operating Income	-11.63	-5.70	-6.53	-6.62	-5.69
Other Income/Expense
Interest Income	0.00	0.01	0.04	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.28	-0.07	-0.22	-0.76	0.00
Income
Income Before Tax	-11.91	-5.81	-6.71	-7.38	-5.69
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-11.90	-5.80	-6.66	-7.27	-4.03
Net Income - Continuous Operations	-11.90	-5.81	-6.71	-7.38	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-11.80	-5.62	-6.39	-6.52	-5.58
EBIT	-11.88	-5.70	-6.53	-6.62	-5.69
Depreciation & Amortization	0.12	0.08	0.15	0.10	0.11
Earnings Per Share
Basic EPS	-1.00	-	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-	-1.00	-1.00	-1.00
Basic Shares Outstanding	18.00	12.38	6.61	5.89	4.39
Diluted Shares Outstanding	18.00	12.38	6.61	5.89	4.39